Biotecnol Limited is a privately held British corporation, part of the Biotecnol SA Group (Portugal). Biotecnol Limited is headquartered in London. Biotecnol Limited investors include Biotecnol SA (Portugal), as well as a variety of family offices and individual investors from across the globe including institutional investors like Caixa Capital and Shire (now part of Takeda). In August 2017 Biotecnol Limited closed a collaboration agreement with Cancer Research UK (CRUK), whereby such a top-tier leading institution in oncology drug development became a shareholder in Biotecnol Limited. This major strategic collaboration has allowed Biotecnol Limited to significantly speed-up the clinical development of its products.